
Probiotics might counter statin-linked blood sugar rise via gut microbiota, editorial says
Louis shares an ATVB editorial describing statin-induced gut microbiota changes as a candidate mechanism for statin-associated new-onset type 2 diabetes. The editorial says causality still needs larger sequencing studies. Louis adds that in JUPITER, high-dose rosuvastatin raised A1C by 0.1, bringing diabetes diagnosis about 5.4 weeks earlier over 2 years, a small but real effect.

